Demuth, Stanislas
Guillaume, Maxime
Bourre, Bertrand
Ciron, Jonathan
Zephir, Hélène
Sirejacob, Yoann
Kerbrat, Anne
Lebrun-Frenay, Christine
Papeix, Caroline
Michel, Laure
Laplaud, David
Vukusic, Sandra
Maillart, Elisabeth
Cohen, Mikael
Audoin, Bertrand
Marignier, Romain
Collongues, Nicolas http://orcid.org/0000-0002-3683-5582
,
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-COHO-002)
Article History
Received: 15 October 2021
Accepted: 21 February 2022
First Online: 2 March 2022
Declarations
:
: All patients gave their informed consent, and data collection was approved by the national ethical authority (Commission Nationale de l'Informatique et des Libertés; CNIL; registration number 914066v2).
: Not applicable.
: HZ has received honoraria from Biogen IDEC, Novartis, Merck, Roche, Alexion, support for travelling from Biogen, Novartis, Merck and Roche. She serves on the advisory board of Novartis. Her institution perceived a grant from Roche. SV reports honoraria from Biogen, Celgene, Merck, Novartis, Roche, Sanofi paid to her institution. EM has received grants or contracts from Roche and Biogen to her institution. She has received consulting fees and support for travelling from Roche, Biogen, Novartis, Merck, Sanofi-genzyme, Teva, Alexion. MC serves on the scientific advisory board for Biogen, Teva, Novartis, Sanofi, Roche, Ad Scientiam and Alexion. RM serves on the scientific advisory board for Viela Bio, Roche, UCB, and Alexion, and has received honoraria from Biogen, Merck, and Novartis. NC serves on scientific advisory boards for, and has received honoraria from, Biogen Idec, Merck Serono, Sanofi-Genzyme, Bayer Schering Pharma, and Alexion Pharmaceutical. SD, MG, BB, JC, YS, AK, CLF, CP, LM, DL and BA reports no disclosures.